Health
UK regulator speeds process to OK coronavirus vaccines for new variants – POLITICO.eu
Oxford/AstraZeneca has said it has begun making a version of its vaccine against a novel variant.
The U.K.s drugs regulator won’t require further large-scale clinical trials to approve modified coronavirus vaccines against new variants, it said on Thursday.
Instead of waiting to see if vaccinated people become infected, as is usually done, the Medicines and Healthcare products Regulatory Agency (MHRA) will require data that show new versions of approved vaccines induce an immune response through blood tests. These studies will be smaller and faster.
The MHRA has developed guidance for the pharmaceutical…
-
Noosa News18 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General21 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News19 hours agoForum responds to urgent homelessness issues in Nambour
-
Business16 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick